Inventor · disambiguated record
Janelle Waite
Also filed as: WAITE JANELLE
4 granted patents·3 pending applications·28 citations·filing 2019–2025
73Inventor score
Files withREGENERON PHARMA7
Top patents by PatentIndex Score
7 records- 0194US11548947B2Bispecific anti-PSMA X anti-CD28 antibodies and uses thereofREGENERON PHARMA·Filed 2019·Granted Jan 10, 2023·10 cites·17 claims
- 0293US11453721B2Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereofREGENERON PHARMA·Filed 2019·Granted Sep 27, 2022·10 cites·30 claims
- 0391US11396544B2Bispecific anti-CD28 × anti-CD22 antibodies and uses thereofREGENERON PHARMA·Filed 2019·Granted Jul 26, 2022·8 cites·10 claims
- 0475US12441800B2Bispecific anti-PSMA x anti-CD28 antibodies and uses thereofREGENERON PHARMA·Filed 2022·Granted Oct 14, 2025·0 cites·14 claims
- 0571US2023174652A1Bispecific Anti-CD28 X Anti-CD22 Antibodies and Uses ThereofREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0668US2025223360A1Bispecific anti-cd28 x anti-cd22 antibodies and uses thereofREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0768US2023279113A1Bispecific Anti-MUC16 x Anti-CD28 Antibodies and Uses ThereofREGENERON PHARMA·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Janelle Waite files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →